Signed in as:
Signed in as:
Let'sTalkPPCM, a nonprofit organization dedicated to raising awareness and promoting the early detection of Peripartum Cardiomyopathy (PPCM), is launching a B-type Natriuretic Peptide (BNP) data collection initiative. This program aims to gather valuable information from high-risk expectant mothers to facilitate early detection of PPCM, ultimately improving maternal health outcomes. As part of this initiative, Let'sTalkPPCM is offering COMPENSATION to participants for their time and blood donation. This guide will outline what you can expect from this data collection process.
The objective of the BNP Data Collection: The BNP data collection initiative by Let'sTalkPPCM aims to identify potential markers of PPCM risk in high-risk pregnant women. By analyzing BNP levels in blood samples, researchers can gain insights into the early signs of PPCM, allowing for earlier diagnosis and intervention.
Participant Eligibility: To participate in the BNP data collection, you must meet the following eligibility criteria:
Data Collection Process: If you choose to participate in the BNP data collection, here's an overview of what you can expect:
Confidentiality and Data Security: Let'sTalkPPCM understands the importance of safeguarding participant privacy and confidentiality. Your personal information and medical data will be kept strictly confidential and will only be used for research purposes with appropriate anonymization.
Benefits and Future Impact: By participating in this BNP data collection, you contribute to the early detection of PPCM, potentially saving lives and improving maternal health outcomes. The research findings from this initiative can lead to better diagnostic tools and treatment strategies for PPCM, benefiting not only high-risk expectant mothers but also the broader medical community.
Conclusion: Let'sTalkPPCM's BNP data collection initiative provides an opportunity for high-risk expectant mothers to actively participate in PPCM research and contribute to early detection efforts. By joining this initiative, you play a vital role in improving maternal health outcomes and raising awareness about PPCM.
PPCM is known as rare, so each participant is crucial. Researchers need to better understand the stories of survivors to successfully develop testing and treatments. By voluntarily sharing information with the PPCM-R, through self-reported survey responses and sharing your PPCM medical record, you can help ensure that the field is focused on aspects of the disease that are most important to survivors.
PPCM-R will start with enrolling USA based PPCM patients in 2023, we anticipate beginning international enrollment in the future. The PPCM-R welcomes those who have been diagnosed with PPCM. Registration is easy and you can choose what information you want to share through surveys and your medical records.
1. To create a database of PPCM survivor medical records driven by patients, with voluntary patient-mediated registration, survey questionnaires, and medical record collection
2. To answer important research questions and ultimately prevent PPCM
3. To be the source reliable information about PPCM, interpreted by experts
4. To be a partner for PPCM advocacy groups in education and research initiatives
Peripartum Cardiomyopathy Awareness Week is May 10-17, 2022 in Texas.❤